Diagnostic work up in gastroesophageal reflux disease;Diagnostik bei gastro-ösophagealer refluxkrankheit

Praxis

Volumn 91, Issue 18, 2002, Pages 779-790

  Allescher, H D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

24 Hour pH monitoring; Barret's esophagus; Chromoendoscopy; NERD; PPI test

Indexed keywords

BARRETT ESOPHAGUS; BIOPSY; COMPARATIVE STUDY; DIGESTIVE TRACT ENDOSCOPY; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMAN; PATHOLOGY; PREDICTION AND FORECASTING; REFLUX ESOPHAGITIS; REVIEW; STOMACH PH;

BARRETT ESOPHAGUS; BIOPSY; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGITIS, PEPTIC; ESOPHAGUS; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 0036561957     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.91.18.779     Document Type: Review

References (104)

1. Nebel O.T., Forbes M.F., Castell D.O.: Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am. J. Dig. Dis. 21, 953-956, 1976.
2. Richter J.E.: Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management. Gastroenterol. Clin. North. Am. 25, 75-102, 1997.
3. Lagergren J., Bergstrom R., Lindgren A., Nyren O.: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med., Mar 340: 825-831, 1999.
4. Reynolds J.C., Waronker M., Pacquing M.S., Yassin R.R.: Barrett's esophagus. Reducing the risk of progression to adenocarcinoma. Gastroenterol. Clin. North. Am. 28, 917-945, 1999.
5. Shi G., Bruley des Varannes S., Scarpignato C., Le Rhun M., Galmiche J-P: Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 37, 457-464, 1995.
6. Trimble K.C., Pryde A., Heading R.C.: Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: Evidence for a spectrum of visceral sensitivity in GORD. Gut 37, 7-12, 1997.
7. Carlsson R., Dent J., Bolling-Sternevald E., Johnsson F., Junghard O., Lauritsen K., Riley S., Lundell L.: The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand. J. Gastroenterol. 33, 1023-1029, 1998. (Pubitemid 28505643)
8. Klauser A.G., Schindlbeck N.E., Muller-Lissner S.A.: Symptoms in gastrooesophageal reflux disease. Lancet 335, 205-208, 1990.
9. Cote D.N., Miller R.H.: The association of gastroesophageal reflux and otolaryngologic disorders. Compr. Ther. 21, 80-84, 1995.
10. Field S.K., Underwood M., Brant R., Cowie R.L.: Prevalence of gastroesophageal reflux symptoms in asthma. Chest. 109, 316-322, 1996. (Pubitemid 26058582)
11. Fraser A.G.: Gastro-oesophageal reflux and laryngeal symptoms. Aliment. Pharmacol. Ther. 8, 265-272, 1994.
12. Jaspersen D., Micklefield G.: Gastroösophagealer Reflux und assoziierte Atemwegserkrankungen. Dtsch. Ärztebl. 94, A915-A916, 1997.
13. Harding S.M., Richter J.E.: The role of gastroesophageal reflux in chronic cough and asthma. Chest. 111, 1389-1402, 1997. (Pubitemid 27200101)
14. Koufman J.A.: The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101, 1-78, 1991.
15. Rasche K., Sanner B., Schafer T., May B.: Sleep, breathing and gastroesophageal reflux. Dtsch. Med. Wochenschr. 122, 659-663, 1997.
16. Tromm A., Micklefield G.H., Huppe D.: Bronchopulmonary manifestations of gastroenterologic and hepatic diseases. Med. Klin. 92, 720-725, 1997. (Pubitemid 28051794)
17. Kiljander T.O., Salomaa E-RM, Hietanen E.K., Terho E.O.: Gastroesophageal reflux in asthmatics. Chest. 116, 1257-1264, 1999.
18. Levin T.R., Sperling R.M., McQuaid K.R.: Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am. J. Gastroenterol. 93, 1060-1063, 1998. (Pubitemid 29080950)
19. Fass R., Fennerty M.B., Ofman J.J., Gralnek I.M., Johnson C., Camargo E., Sampliner R.E.: The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 115, 42-49, 1998. (Pubitemid 28307286)
20. Singh S., Richter J.E., Hewson E.G., Sinclair J.W., Hackshaw B.T.: The contribution of gastroesophageal reflux to chest pain in patients with coronary artery disease. Ann. Intern. Med. 117, 824-830, 1992.
21. Dent J., Brun J., Fendrick A.M., Fennerty M.B., Janssens J., Kahrilas P.J., Lauritsen K., Reynolds J.C., Shaw M., Talley N.J.: On behalf of the Genval Workshop Group, An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 44, 1-16, 1999.
22. Wilkinson S.P.: The limits of endoscopy in the diagnosis of oesophagitis, gastritis and duodenitis. Aliment. Pharmacol. Ther. 11, 13-17, 1997.
23. Siewert J.R., Ottenjann R., Heilmann K., Neiss A., Dopfer H.: Therapy and prevention of reflux esophagitis. Results of a multicenter study with cimetidine. I: Epidemiology and results of acute therapy. Z. Gastroenterol. 8, 381-395, 1986.
24. Armstrong D., Emde C., Inauen W., Blum A.L.: Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical? Hepatogastroenterology 39, Suppl 1, 3-13, 1992.
25. Schindlbeck N.E., Wiebecke B., Klauser A.G., Voderholzer W.A., Muller- Lissner S.A.: Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut 39, 151-154, 1996. (Pubitemid 26275986)
26. Sampliner R.E.: Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am. J. Gastroenterol. 93, 1028-1032, 1998.
27. Johnson D.A., Winters C., Spurling T.J., Chobanian S.J., Cattau E.L., Jr.: Esophageal acid sensitivity in Barrett's esophagus. J. Clin. Gastroenterol. 9, 23-27, 1987. (Pubitemid 17035252)
28. Grunewald M., Vieth M., Kreibich H., Bethke B., Stolte M.: Untersuchungen zum Stand der Diagnostik des Barrett-Ösophagus'. Med. Wochenschr. 122, 427-431, 1997. (Pubitemid 27179710)
29. Sampliner R.E.: Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am. J. Gastroenterol. 93, 1028-1032, 1998.
30. Nandurkar S., Talley N.J., Martin C.J., Ng T.H., Adams S.: Short segment Barrett's oesophagus: Prevalence, diagnosis and associations. Gut 40, 710-715, 1997. (Pubitemid 27305461)
31. Sharma P., Morales T.G., Samplinger R.E.: Short segment Barrett's esophagus - the need for standardization of the definition and of endoscopic criteria. Am. J. Gastroenterol. 93, 1033-1036, 1998. (Pubitemid 29080945)
32. Nandurkar S., Talley N.J.: Barrett's esophagus: The long and the short of it. Am. J. Gastroenterol. 94, 30-40, 1999. (Pubitemid 29063441)
33. Levine D.S., Haggitt R.C., Blount P.L., Rabinovitch P.S., Rusch V.W., Reid B J: An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105, 40-50, 1993. (Pubitemid 23234018)
34. Hameeteman W., Tytgat G.N., Houthoff H.J., van den Tweel J.G.: Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 96, 1249-1256, 1989. (Pubitemid 19126659)
35. Miros M., Kerlin P., Walker N.: Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 32, 1441-1446, 1991.
36. Robertson C.S., Mayberry J.F., Nicholson D.A., James P.D., Atkinson M.: Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br. J. Surg. 75, 760-763, 1988.
37. Gray M.R., Hall P.A., Nash J., Ansari B., Lane D.P., Kingsnorth A.N.: Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalisation. Gastroenterology 103, 1769-1776, 1992.
38. Kim R., Clarke M.R., Melhelm M.F.: Expression of p53, PCNA and C-erbB-2 in Barrett's metaplasia and adenocarcinoma. Dig. Dis. Sci. 42, 2453-2462, 1997. (Pubitemid 28103779)
39. Flejou J.F., Paraf F., Muzeau F.: Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: Pathological and prognostic correlations. J. Clin. Pathol. 47, 23-26, 1994 (Pubitemid 24057743)
40. Jankowski J.A., Wright N.A., Meltzer SJ: Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am. J. Pathol. 154, 965-973, 1999.
41. Neshat K., Sanchez C.A., Galipeau P.C., Blount P.L., Levine D.S., Joslyn G., Reid B.J.: p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 106, 1589-1595, 1994.
42. Ramel S., Reid B.J., Sanchez C.A., Blount P.L., Levine D.S., Neshat K., Haggitt R.C., Dean P.J., Thor K., Rabinovitch P.S.: Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology 102, 1220-1228, 1992.
43. Schlemper R.J., Riddell R.H., Kato Y., et al.: The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47, 251-255, 2000. (Pubitemid 30489769)
44. Geboes K., van Eyken P.: The diagnosis of dysplasia and malignancy in Barrett's esophagus. Histopathology 37, 99-107, 2000. (Pubitemid 30608506)
45. Heitmiller R.F., Redmond M., Hamilton S.R.: Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann. Surg. 224, 66-71, 1996. (Pubitemid 26227409)
46. Buttar N.S., Wang K.K., Sebo T.J., Riehle D.M., Krishnadath K.K., Lutzke L.S., Anderson M.A., Petterson T.M., Burgart L.J.: Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120, 1630-1639, 2001. (Pubitemid 32523482)
47. Gerzic Z.B.: Modification of the Merendino procedure. Dis. Esophagus, 10, 270-275, 1997.
48. Canto M.I., Setrakian S., Petras R.E., Blades E., Chak A., Sivak M.V., Jr.: Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest. Endosc. 44, 1-7, 1996. (Pubitemid 26268651)
49. Chobanian S.J., Cattau E.L., Jr., Winters C., Jr., Johnson D.A., van Ness M.M., Miremadi A., Horwitz S.L., Colcher H.: In vivo staining with toluidine blue as an adjunct to the endoscopic detection of Barrett's esophagus. Gastrointest. Endosc. 33, 99-101, 1987. (Pubitemid 17050486)
50. Stevens P.D., Lightdale C.J., Green P.H., Segel L.M., Garcia-Carrasquillo R.J., Rotterdam H.: Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. Gastrointest. Endosc. 40, 747-749, 1994. (Pubitemid 24366592)
51. Jung M., Kiesslich R.: Chromoendoscopy and intravital staining techniques. Baillieres Best Pract. Res. Clin. Gastroenterol. 1, 11-19, 1999, Apr. (Pubitemid 29322497)
52. Kiesslich R., Hahn M., Herrmann G., Jung M.: Screening for specialized columnar epithelium with methylene blue: chromoendoscopy in patients with Barrett's esophagus and a normal control group. Gastrointest. Endosc. 53, 47-52, 2001. (Pubitemid 32109449)
53. Sharma P., Topalovski M., Mayo M.S., Weston A.P.: Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus. Gastrointest. Endosc. 54, 289-293, 2001. (Pubitemid 33665506)
54. Wallace M.B., Perelman L.T., Backman V., Crawford J.M., Fitzmaurice M., Seiler M., Badizadegan K., Shields S.J., Itzkan I., Dasari R.R., van Dam J., Feld M.S.: Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy. Gastroenterology 119, 677-682, 2000.
55. Pfau P., Chak A.: Detection of preinvasive cancer cells: early-warning changes in precancerous epithelial cells can now be spotted in situ and Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattered spectroscopy. Gastrointest. Endosc. 54, 414-416, 2001.
56. Egger K., Rösch T., Allescher H.D., Ott R., Kurjak K., Werner M., Classen M.: Videoendoscopy and stepwise biopsy of Barrett's esophagus are still necessary despite sophisticated diagnostic methods, Gastroenterology 118, 2000, A.
57. Endlicher E., Knuechel R., Hauser T., Szeimies R.M., Scholmerich J., Messmann H.: Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation. Gut 48, 314-319, 2001. (Pubitemid 32269557)
58. Messmann H., Knuchel R., Baumler W., Holstege A., Scholmerich J: Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation. Gut 48, 314-319, 2001.
59. Ray M.B., Mayfield-Stokes S., Cecil B.: Results of methylene-blue- directed biopsy is similar to conventional biopsy for the diagnosis of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest. Endosc. 49, 1999, AB 54.
60. Pace F., Annese V., Ceccatelli P., Fei L.: Ambulatory oesophageal pH-metry. Position paper of the Working Team on Oesophageal pH-metry by the GISMAD (Gruppo Italiano di Studio sulla Motilita dell'Apparato Digerente). Dig. Liver. Dis. 32, 357-364, 2000. (Pubitemid 30445076)
61. Eckhardt V.F., Dilling B., Bernhard G.: The impact of open access 24-h pH-metry on the diagnosis and management of esophageal reflux disease. Am. J. Gastroenterol. 94, 616-621, 1999. (Pubitemid 29124855)
62. Fuchs K-H, Feussner H., Bonavini L., Collard J.M., Coosemans W.: Current status and trends in laparoscopic antireflux surgery: Results of a consensus conference. Endoscopy 29, 298-308, 1997. (Pubitemid 27322936)
63. Seige M., Ott R., Allescher H.D.: Ösophagusmanometrie, 24-Stunden-pHMetrie und Provokationstests. Verdauungskrankheiten 13, 215-229, 1995.
64. Bollschweiler E., Feussner H., Holscher A.H., Siewert J.R.: pH monitoring: the gold standard in detection of gastrointestinal reflux disease? Dysphagia 8, 118-121, 1993. (Pubitemid 23144073)
65. Bumm R., Hölscher A.H.: The role of esophageal motility in gastroesophageal reflux disease: technique and clinical results of ambulatory 24-hour mano/-pH-metry. Dysphagia 8, 112-117, 1993. (Pubitemid 23144072)
66. Booth M.I., Dehn T.C.: Twenty-four-hour pH monitoring is required to confirm acid reflux suppression in patients with Barrett's oesophagus undergoing anti-reflux surgery. Eur. J. Gastroenterol. Hepatol. 13, 1323-1326, 2001. (Pubitemid 33111978)
67. Chen L.Q., Hu C.Y., Gaboury L., Pera M., Ferraro P., Duranceau A.C.: Proliferative activity in Barrett's esophagus before and after antireflux surgery. Ann. Surg. 234, 172-180, 2001. (Pubitemid 32729423)
68. Srinivasan R., Katz P.O., Ramakrishnan A., Katzka D.A., Vela M.F., Castell D.O.: Maximal acid reflux control for Barrett's oesophagus: feasible and effective. Aliment. Pharmacol. Ther. 15, 519-524, 2001. (Pubitemid 32242778)
69. Peters F.T., Ganesh S., Kuipers E.J., Sluiter W.J., Karrenbeld A., de Jager- Krikken A., Klinkenberg-Knol E.C., Lamers C.B., Kleibeuker J.H.: Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett's esophagus. Scand. J. Gastroenterol. 35, 1238-1244, 2000. (Pubitemid 32051635)
70. Castell D.O.: Acid suppression therapy in Barrett's esophagus: the importance of pH monitoring. Curr. Gastroenterol. Rep. 2, 173-174, 2000.
71. Janssens J.P., Vantrappen G.: Irritable esophagus, Am. J. Med. 27; 27-32, 1992.
72. Hölscher A.H., Bollschweiler E., Bumm R: pH-Metrie von Ösophagus und Magen, in: Classen M, Siewert JR: Gastroenterologische Diagnostik Schattauer, Stuttgart, 139-153, 1995.
73. Mattioli S., Felice V., Pilotti V., Bacchi M.L., Pastina M., Gozzetti G.: Indications for 24-hour gastric pH monitoring with single and multiple probes in clinical research and practice. Dig. Dis. Sci. 37, 1793-1801, 1992. (Pubitemid 23026467)
74. Stein H.J.: Clinical use of ambulatory 24-hour esophageal motility monitoring in patients with primary esophageal motor disorders. Dysphagia 8, 105-111, 1993.
75. Ott D.J., Ledbetter M.S., Koufinan J.A., Chen M.Y.: Globus pharyngeus: radiographic evaluation and 24-hour pH monitoring of the pharynx and esophagus in 22 patients. Radiology 191, 95-97, 1994. (Pubitemid 24098209)
76. Schindlbeck N.E., Heinrich C., Konig A., Dendorfer A., Pace F., Muller- Lissner S.A.: Optimal thresholds, sensitivity and specificity of long-term pHmetry for the detection of gastroesophageal reflux. Gastroenterology 93, 85-90, 1987. (Pubitemid 17084098)
77. Schindlbeck N.E., Ippisch H., Klauser A.G., Muller-Lissner S.A.: Which pH threshold is best in esophageal pH monitoring? Am. J. Gastroenterol. 86, 1138-1141, 1991.
78. Smout A.J., Breedijk M., van-der-Zouw C., Akkermans LM: Physiological gastroesophageal reflux and esophageal motor activity studied with a new system for 24-hour recording and automated analysis. Dig. Dis. Sci. 34, 372-378, 1989.
79. Emde C.: Ambulante Langzeit-pH-Metrie der Speiseröhre. Z. Gastroenterol. 20, 373-375, 1982.
80. Emde C., Gamer A., Blum A.L.: Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut 28, 1177-1188, 1987. (Pubitemid 17154486)
81. Klauser A.G., Schindlbeck N.E., Muller-Lissner S.A.: Esophageal 24- hour pH monitoring: is prior manometry necessary for correct positioning of the electrode? Am. J. Gastroenterol. 85, 1463-1467, 1990.
82. Zhu H., Pace F., Sangaletti O., Santalucia F., Bianchi-Porro G.: pH fluctuations versus reflux episodes in patients with gastroesophageal reflux disease: their optimal thresholds and significance in diagnosis Digestion 57, 152-160, 1992.
83. Lam H.G., Breumelhof R., Roelofs J.M., van-Berge-Henegouwen G.P., Smout A.J.: What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig. Dis. Sci. 59, 402-409, 1994. (Pubitemid 24073618)
84. Richter J.E., Bradley L.A., DeMeester T.R., Wu W.C.: Normal 24-hour ambulatory esophageal pH values - influence of study center, pH-electrode, age, and gender. Dig. Dis. Sci. 37, 849-856, 1992.
85. Richter J.E., Castell D.O.: 24-hour ambulatory oesophageal motility monitoring: how should motility data be analysed? Gut 30, 1040-1047, 1989. (Pubitemid 19202199)
86. Johnson L.F., DeMeester T.R.: Development of the 24-hour intraesophageal pH monitoring composite scoring system. J. Clin. Gastroenterol. 8, Suppl. 1, 52-58, 1986.
87. Vaezi M.F., Shay S.S.: New techniques in measuring nonacidic esophageal reflux. Semin. Thorac. Cardiovasc. Surg. 13, 255-264, 2001. (Pubitemid 32952326)
88. Dixon M.F., Neville P.M., Mapstone N.P., Moayyedi P., Axon A.T.: Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux? Gut 49, 359-363, 2001. (Pubitemid 32802570)
89. Barrett M.W., Myers J.C., Watson D.I., Jamieson G.G.: Detection of bile reflux: in vivo validation of the Bilitec fibreoptic system. Dis. Esophagus. 13, 44-50, 2000.
90. Menges M., Muller M., Zeitz M.: Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am. J. Gastroenterol. 96, 331-337, 2001.
91. Manifold D.K., Marshall R.E., Anggiansah A., Owen W.J.: Effect of omeprazole on antral duodenogastric reflux in Barrett's oesophagus. Scand. J. Gastroenterol. 35, 796-801, 2000.
92. Sifrim D., Holloway R., Silny J., Xin Z., Tack J., Lerut A., Janssens J.: Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 120, 1588-1598, 2001. (Pubitemid 32523478)
93. Sifrim D., Holloway R., Silny J., Tack J., Lerut A., Janssens J.: Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am. J. Gastroenterol. 96, 647-655, 2001. (Pubitemid 32240710)
94. Castell D.O., Richter J.E., Dalton D.B.: Esophageal motility testing. Elsevier, New York 1987.
95. Dodds W.J.: Instrumentation and methods for intraluminal esophageal manometry. N. Engl. J. Med. 307, 1547-1552, 1982.
96. Feussner H.: Ösophagusmanometrie. In: Classen M., Siewert J.R.: Gastroenterologische Differentialdiagnostik. Schattauer, Stuttgart 155-170, 1993.
97. Freidin N., Eidelman S., Danieli Z., Bergman I.: Insertion of Dent sleeve catheter using a guidewire in achalasia. Gastrointest. Endosc. 38, 699-700, 1992. (Pubitemid 23006386)
98. Freys S.M., Heuer-Johnk U.: Stationäre Ösophagusmanometrie. In: Fuchs K.H., Hamelmann H.: Gastrointestinale Funktionsdiagnostik in der Chirurgie. Blackwell, Berlin 255-273, 1991.
99. Mittal R.K., McCallum R.W.: Characteristics of transient lower esophageal sphincter relaxation in humans. Am. J. Physiol. 252, G636-G641, 1987.
100. Massey B.T., Dodds W.J., Hogan W.J., Brasseur J.G., Helm J.F.: Abnormal esophageal motility. Gastroenterology 101, 344-354, 1991.
101. Fuchs K.-H., Feussner H., Bonavini L., Collard J.M., Coosemans W.: Current status and trends in laparoscopic antireflux surgery: Results of a consensus conference. Endoscopy 29, 298-308, 1997.
102. Freys S.M., Fuchs K.H., Heimbucher J., Thiede A.: Tailored augmentation of the lower esophageal sphincter in experimental antireflux operations. Surg. Endosc. 11, 1183-1188, 1997. (Pubitemid 127524455)
103. Hannig C., Wuttge-Hannig A.: Röntgen-Kinematographie des Pharynx und des Ösophagus. In: Classen M., Siewert J.R.: Gastroenterologische Differentialdiagnostik. Schattauer, Stuttgart 93-103, 1993.
104. Tatsch K., Voderholzer W.A., Weiss M.J., Schroettle W., Klauser A.G., Müller-Lissner S.A., Kirsch C.M.: Simultaneous assessment of bolus transport and contraction parameters in multiple-swallow investigations. J. Nucl. Med. 33, 1291-1300, 1992.